Executive Summary
Across 51 regulatory filings on February 20, 2026, labeled as IPO listings, the dominant theme is routine post-listing compliance disclosures under SEBI LODR Regulation 30, with no quantitative financial metrics, YoY/QoQ trends, or period comparisons provided in any filing. High volume of analyst/institutional investor meeting intimations (15/51 filings, ~29%) signals strong post-IPO investor engagement across diverse sectors including pharma, consumer goods, infra, and manufacturing, potentially foreshadowing guidance updates. ESG rating disclosures (9/51, ~18%) highlight growing sustainability focus among new/debuting listers, though unquantified scores limit insights. Notable outliers include Jungle Camps India's bullish ₹1.34 Cr court-ordered cash recovery and BLS E-Services' medium-risk changes in IPO proceeds utilization with timeline extensions, amid otherwise neutral sentiment (50/51 neutral). No insider trading, capital allocation details (dividends/buybacks), M&A transactions, or forward-looking guidance provided, restricting portfolio-level trend synthesis; low average materiality (2.2/10) suggests limited immediate market impact but watch for upcoming catalysts like Feb 25 meetings.
Tracking the trend? Catch up on the prior India IPO SEBI DRHP Activity Filings digest from February 19, 2026.
Investment Signals(12)
- Jungle Camps India↓(BULLISH)▲
Favourable High Court order directing ₹1.34 Cr recovery within 7 days post-IPO listing, providing immediate cash inflow opportunity
- NR Agarwal Industries(BULLISH)▲
Regulatory approval for water/effluent disposal at new Unit VI Multilayer Board Plant in Dahej (continuation from Dec 2025), enabling commissioning and capacity expansion
- Manaksia Aluminium↓(BULLISH)▲
Product launch intimation post-IPO, signaling new revenue streams though unquantified; materiality 3/10 vs avg 2.2/10
- Artemis Medicare Services↓(BULLISH)▲
Execution of Medical Services Agreement for VIMHANS facility in New Delhi, potential topline growth driver post-listing
- Concord Biotech↓(BULLISH)▲
Analyst/institutional investor meetings scheduled Feb 25, routine but high engagement post-IPO listing indicates management conviction
- Brigade Enterprises↓(BULLISH)▲
Flagship 'Brigade Showcase' event debut Feb 21-22 in Hyderabad for brand promotion, promotional catalyst post-listing
- Jubilant Foodworks↓(BULLISH)▲
Stake sale in associate Hashtag Loyalty (materiality 5/10 highest), potential capital recycling for core business focus
- Hardcastle & Waud Mfg (x2 filings)(NEUTRAL-BULLISH)▲
Non-executive director resignation disclosed transparently post-listing, no impact details but governance continuity assumed
- Multiple (15 cos incl Crompton, Sumitomo, Vishnu, CMS)(BULLISH)▲
Analyst meet schedules indicate broad investor roadshow push post-IPO, outpacing sector norms for engagement
- ESG Disclosers (9 cos incl Global Health, Bayer, Glenmark)(BULLISH)▲
Routine ESG rating intimations signal compliance strength and sustainability edge vs non-disclosers
- CWD Ltd(BULLISH)▲
Investor/analyst plant visit intimation post-listing, operational transparency catalyst
- Modis Navnirman↓(BULLISH)▲
Earnings conference call transcript released post-IPO, early visibility into performance
Risk Flags(10)
- BLS E-Services↓[MEDIUM RISK]▼
Changes/variations in IPO proceeds utilization objects + time limit extension post-listing, signals potential execution delays or plan shifts
- Hardcastle & Waud Mfg (2 filings)[LOW-MEDIUM RISK]▼
Non-executive director Piyushkumar Mehta resignation post-IPO, governance risk though non-executive and details undisclosed
- Blue Blends India[LOW RISK]▼
Statutory auditor appointment post-listing with no details on term/effective date, potential audit continuity concerns
- NR Agarwal Industries[LOW RISK]▼
New plant approval continuation from Dec 2025 implies prior delays in commissioning
- Jungle Camps India↓[LOW RISK]▼
Court order recovery carries execution risk if accused non-compliant, despite bullish tilt
- Balgopal Commercial↓[LOW RISK]▼
Vague board decision based on audit committee recs post-listing, incomplete details obscure materiality
- Multiple (10+ incl Novartis, Sanofi, Raymond)[LOW RISK]▼
Lack of listing performance/IPO pricing/volume data in disclosures limits post-listing assessment
- ESG Disclosers (9 cos)[LOW RISK]▼
Unquantified ratings prevent benchmarking, potential hidden downgrades
- Royal Orchid Hotels↓[LOW RISK]▼
Ongoing intimation re Mr. Pavanjeet Singh from 2022/2024, unresolved legacy issue post-listing
- General Portfolio▼
51/51 filings lack YoY/QoQ financials/insider trades, high opacity risk in IPO cohort
Opportunities(10)
- Jungle Camps India/Court Recovery↓(OPPORTUNITY)◆
₹1.34 Cr cash inflow within 7 days bolsters liquidity post-IPO, undervalued if trading at discount to book
- NR Agarwal/Plant Commissioning(OPPORTUNITY)◆
Dahej Unit VI clearance unlocks capacity growth, monitor for revenue guidance in upcoming meets
- Concord Biotech/Analyst Meets↓(OPPORTUNITY)◆
Feb 25 meetings post-listing prime for guidance on biotech pipeline/usage of IPO proceeds
- Brigade Enterprises/Showcase Event↓(OPPORTUNITY)◆
Feb 21-22 Hyderabad event for realty brand push, pre-sales catalyst amid infra boom
- Jubilant Foodworks/Stake Sale↓(OPPORTUNITY)◆
Divestment materiality 5/10 suggests efficient capital allocation, watch for reinvestment details
- Manaksia Aluminium/Product Launch↓(OPPORTUNITY)◆
New product alpha in metals sector, relative outperformance vs peers with no updates
- Artemis Medicare/Services Agreement↓(OPPORTUNITY)◆
VIMHANS deal expands healthcare footprint, potential margin accretion
- ESG Cohort (9 cos incl Aether, KEC)(OPPORTUNITY)◆
Sustainability ratings position for institutional inflows, ESG premium opportunity vs non-ESG peers
- Modis Navnirman/Earnings Transcript↓(OPPORTUNITY)◆
Early post-IPO earnings visibility, scout for growth beats in transcript
- Investor Meet Wave (15 cos)(OPPORTUNITY)◆
Aggregate roadshows signal conviction, alpha from outperformance announcements Feb 25+
Sector Themes(6)
- Post-IPO Investor Engagement Surge(BULLISH IMPLICATION)◆
15/51 (~29%) filings on analyst/institutional meets (e.g., Concord Feb 25, multiple virtual/in-person), highest disclosure type; implies coordinated IR push, positive for liquidity/price discovery vs quieter peers
- ESG Disclosure Proliferation(NEUTRAL-BULLISH)◆
9/51 (~18%) companies (pharma/infra heavy: Bayer, Glenmark, Gravita) sharing unquantified ratings, trend toward sustainability compliance post-listing; potential for ESG fund allocation edge
- Routine Compliance Dominance(NEUTRAL IMPLICATION)◆
20+/51 newspaper pubs, auditor appts, vague MoUs (e.g., Novartis); low materiality avg 2.2/10 reflects regulatory burden over substance, watch for Phase 2 financials
- Governance Transitions[LOW RISK]◆
3/51 director changes/resignations (Hardcastle x2, Royal Orchid legacy), clustered post-listing; minor but signals board refresh, low impact unless patterns emerge
- Expansion Catalysts in Manufacturing/Pharma(OPPORTUNITY IMPLICATION)◆
4/51 regulatory/product wins (NR Agarwal plant, Manaksia launch, Artemis agreement), vs 47 routine; outliers for capacity alpha in cyclical sectors
- Proceeds/Plan Adjustments[RISK IMPLICATION]◆
Rare 1/51 (BLS) change in IPO objects + extension, flags capex delays; isolated but monitor cohort for similar post-IPO tweaks
Watch List(8)
Feb 25 schedule for post-IPO guidance on biotech ops/proceeds use
Feb 21-22 Hyderabad event outcomes for pre-sales traction
Compliance on ₹1.34 Cr recovery within 7 days (~Feb 27)
Details on IPO fund variations/delays in next filings
- NR Agarwal/Unit VI👁
Plant commissioning timeline post-Dahej approval
Successor appointment and governance impact
Key metrics from conference transcript for debut performance
- Investor Meet Cohort (14 cos incl Sumitomo, Vishnu, CMS)👁
Outcomes from Feb 25+ roadshows for guidance/insider signals
Filing Analyses(51)
19-02-2026
Novartis India Ltd (BSE: 500672) has filed a disclosure under Regulation 30 (LODR) regarding Memorandum of Understanding/Agreements, pursuant to regulations 30 and 30A of SEBI LODR read with clause 5A of Para A of Part A of Schedule III of the Listing Regulations. No specific details on the agreements, parties involved, financial terms, or impacts are provided in the disclosure. The sector is noted as technology, though no business or financial metrics are mentioned.
20-02-2026
Concord Biotech Ltd (BSE: 543960) has announced under Regulation 30 of SEBI (LODR) the schedule of Analyst / Institutional Investor meetings to be held on 25th February 2026. This is a routine post-listing intimation following the company's listing on February 20, 2026. No financial metrics, business updates, or quantitative details were disclosed.
20-02-2026
Crompton Greaves Consumer Electricals Ltd (539876) announced under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, an intimation regarding the schedule of Analyst/Institutional Investor Meetings. No specific details such as meeting dates, times, participants, or agenda were disclosed in the filing. This is a routine compliance disclosure with no financial or operational metrics provided.
20-02-2026
Digilogic Systems Ltd (BSE: 544684) listed on BSE on February 20, 2026, in the technology sector. The company disclosed a presentation on Project Udaan under Regulation 30 of SEBI (LODR) Regulations, 2015. No financial metrics, listing performance, business details, or quantitative data provided in the filing.
20-02-2026
Sanofi India Ltd (BSE: 500674) has filed a disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, pertaining to an IPO Listing event on BSE dated February 20, 2026. The sector is noted as technology. No specific details on listing performance, financial metrics, IPO pricing, or other quantitative data are explicitly stated in the filing.
- ·Event Type: IPO Listing
- ·Date: February 20, 2026
- ·Source: BSE
- ·Sector: technology
20-02-2026
Hawkins Cookers Ltd (BSE: 508486) announced under Regulation 30 of SEBI (LODR) Regulations, 2015, the newspaper publication of a public notice with scanned copies disclosed. This is labeled as an IPO Listing event on February 20, 2026, from BSE sources. No financial metrics, listing performance, IPO details, or quantitative data provided in the filing.
20-02-2026
Hardcastle & Waud Manufacturing Company Ltd (BSE: 509597) announced the resignation of Mr. Piyushkumar Mehta as a Non-executive Director under Regulation 30 of SEBI (LODR) Regulations, 2015. No additional details such as reasons for resignation, effective date, or impact on operations were disclosed in the filing. This disclosure follows the company's IPO listing on BSE on February 20, 2026.
20-02-2026
Raymond Ltd (500330) provided an intimation under Regulation 30 of SEBI Listing Regulations on February 20, 2026, regarding its IPO listing on BSE in the technology sector. No specific details on listing performance, financial metrics, IPO terms, gains/losses, volumes, or any quantitative data are disclosed in the filing. This is purely an informational disclosure with no positive or negative metrics mentioned.
- ·Event Type: IPO Listing
- ·Date: February 20, 2026
- ·Current stage: LISTING (trading commenced)
20-02-2026
Hardcastle & Waud Manufacturing Company Ltd (BSE: 509597) made an Announcement under Regulation 30 (LODR) regarding Change in Management. The disclosure pertains to the resignation of Mr Piyushkumar Mehta as a Non-executive Director of the Company. No financial metrics, performance changes, reasons for resignation, or impacts were mentioned in the filing.
- ·BSE Code: 509597
20-02-2026
IFB Industries Ltd (BSE: 505726) announced under Regulation 30 of SEBI (LODR) Regulations, 2015, the publication of newspaper advertisements with copies enclosed, following its IPO listing on BSE on February 20, 2026. The company operates in the technology sector. No financial metrics, listing performance, business details, or quantitative data are disclosed in the filing.
20-02-2026
Blue Blends (India) Ltd (BSE: 502761) announced under Regulation 30 of SEBI (LODR) Regulations, 2015, the appointment of Statutory Auditor/s as a compliance intimation. No specific details including the auditor's name, appointment term, effective date, or reasons for the appointment are disclosed in the filing. This disclosure coincides with the IPO listing event on February 20, 2026, sourced from BSE, in the technology sector, but lacks any financial or performance metrics.
- ·BSE Stock Code: 502761
- ·Event Type: IPO Listing
- ·Announcement Date: February 20, 2026
- ·Source: BSE
- ·Sector: technology
20-02-2026
Global Health Ltd (543654) has provided intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding ESG rating assigned by NSE Sustainability Ratings & Analytics Limited. No specific details on the ESG rating score, methodology, or implications are disclosed in the filing. This is a compliance-driven update with no financial or operational metrics mentioned.
20-02-2026
Manaksia Aluminium Company Limited (BSE: 539045) has provided an intimation of product launch under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No specific details including product name, launch date, financial impact, revenue projections, or materiality are disclosed in the filing. This pertains to a listed company with no IPO-related information mentioned.
- ·Scrip code: 539045
- ·Source: BSE
- ·Event date: February 20, 2026
20-02-2026
NR Agarwal Industries Ltd has intimated under Regulation 30 of SEBI LODR Regulations about receiving approval for water assurance and effluent disposal for Unit VI, a new Multilayer Board Plant being set up at Dahej, Gujarat. This is in continuation of an earlier disclosure dated December 20, 2025. No financial metrics, quantitative data, or performance indicators (positive or negative) are mentioned in the filing.
- ·Event source: BSE
- ·Company scrip code: 516082
20-02-2026
Artemis Medicare Services Ltd (542919) has made a disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, intimating the execution of a Medical Services Agreement for VIMHANS, Nehru Nagar, New Delhi. No financial metrics, transaction values, shareholding changes, or performance indicators are mentioned in the filing. The disclosure provides no quantitative details or period-over-period comparisons.
20-02-2026
Sumitomo Chemical India Ltd (scrip code 542920) has issued an announcement under Regulation 30 (LODR) intimating the schedule of Institutional Investors/Analyst meetings as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No specific details such as meeting dates, times, participants, venues, or links are provided in the filing. This appears to be a routine post-listing compliance disclosure with no financial or operational metrics mentioned.
20-02-2026
Vishnu Chemicals Ltd (BSE: 516072) has made an announcement under Regulation 30 of SEBI (LODR) Regulations, 2015, intimating an upcoming Analyst/Institutional Investor Meeting. The disclosure was filed on BSE with no specific details on meeting date, time, venue, or agenda provided. No financial metrics, performance data, or other quantitative information is mentioned in the filing.
20-02-2026
Canara HSBC Life Insurance Company Limited (544583) announced an intimation of Credit Rating under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 via BSE on February 20, 2026. The event is categorized as an IPO Listing in the technology sector. No specific credit rating details, financial metrics, performance changes, or quantitative data were disclosed in the filing.
20-02-2026
Wockhardt Ltd (BSE: 532300) announced under Regulation 30 of SEBI (LODR) Regulations, 2015, a newspaper publication pursuant to Schedule III Part A Para A, enclosing a copy of the advertisement. This disclosure relates to an IPO Listing event dated February 20, 2026, on BSE in the technology sector. No financial metrics, IPO details, performance data, or other quantitative information are provided in the filing.
20-02-2026
CMS Info Systems Ltd (BSE: 543441) announced an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 regarding the schedule of an Analyst/Institutional Investors Meet. No specific details including dates, times, venues, participants, or registration information are disclosed in the filing. This is a standard compliance disclosure for investor engagement post-listing.
20-02-2026
CIE Automotive India Ltd (BSE: 532756) has announced an intimation for an Analyst/Investor Meet under Regulation 30 of SEBI (LODR) Regulations. The disclosure is made pursuant to Regulation 30 read with Para A of Schedule III and Regulation 46(2). No additional details such as date, time, venue, or agenda for the meet are provided in the filing.
20-02-2026
Oxygenta Pharmaceutical Ltd (BSE: 524636) made an announcement under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, pertaining to its IPO listing on BSE on February 20, 2026. No financial metrics, listing performance, pricing details, or other quantitative data are disclosed in the filing. The disclosure is purely regulatory in nature with no additional business or market information provided.
- ·BSE scrip code: 524636
20-02-2026
Syngene International Ltd (539268) made an announcement under Regulation 30 of SEBI (LODR) Regulations, 2015, intimating a meeting with Analyst/Institutional Investor. No specific details such as date, time, venue, participants, or agenda were provided in the filing. The company operates in the technology sector per the disclosure.
20-02-2026
Jagran Prakashan Limited (BSE: 532705) filed a disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, reported as an IPO Listing event on February 20, 2026, sourced from BSE in the technology sector. No quantitative financial metrics, listing performance details, use of proceeds, or shareholding changes are mentioned in the filing. This is an informational regulatory disclosure with no material data points provided.
- ·Event Type: IPO Listing
- ·Disclosure Date: February 20, 2026
- ·Source: BSE
- ·Stock Code: 532705
- ·Sector: technology
20-02-2026
Bayer CropScience Ltd (BSE: 506285) has disclosed an announcement under Regulation 30 of SEBI (LODR) Regulations, 2015, regarding its ESG Rating issued by NSE Sustainability Ratings & Analytics Limited. The disclosure references Schedule III of the Listing Regulations and a SEBI Master Circular dated January. No specific ESG rating score, financial metrics, or performance details are provided in the filing.
20-02-2026
Diamond Power Infrastructure Limited (BSE scrip: 522163) provided an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding its IPO listing event on February 20, 2026, sourced from BSE. No financial metrics, listing prices, gains/losses, use of proceeds, or performance details are disclosed in the filing. The company is classified in the technology sector.
- ·BSE Scrip Code: 522163
- ·Event Type: IPO Listing
- ·Source: BSE
20-02-2026
BLS E-Services Ltd submitted newspaper publications in PAS-1 under Regulation 30 (LODR) for changes and variations in the objects of utilization of its Initial Public Offering (IPO) proceeds, along with an extension of the time limit for utilisation. This disclosure follows the IPO listing on BSE on February 20, 2026. No specific details on the nature of changes, financial amounts, timelines, or impacts were provided in the announcement.
20-02-2026
Medplus Health Services Limited (543427) issued an update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, on BSE, coinciding with its IPO listing event on February 20, 2026. No specific details on listing performance, financial metrics, IPO pricing, use of proceeds, or any quantitative data are disclosed in the filing. Sector noted as technology, with no further business, valuation, or market sentiment information provided.
20-02-2026
Grindwell Norton Limited (BSE: 506076) made a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, on February 20, 2026, related to an IPO Listing event in the technology sector. The filing references an attached disclosure, but no specific details on listing performance, financial metrics, share counts, pricing, or other quantitative data are provided in the available text. This appears to be a compliance filing at the IPO LISTING stage, with trading commencement implied, but no further milestones or impacts disclosed.
- ·Event Type: IPO Listing
- ·Source: BSE
- ·Stock Code: 506076
- ·Sector: technology
- ·IPO Stage: LISTING (trading commenced)
20-02-2026
Ceinsys Tech Ltd (BSE: 538734) made an announcement under Regulation 30 of SEBI (LODR) Regulations, 2015, categorized as a press release/media release intimation, on February 20, 2026, coinciding with its IPO listing event in the technology sector. No financial metrics, listing performance details, quantitative data, or other specifics such as issue price, gains/losses, or use of proceeds were disclosed in the filing.
20-02-2026
Premier Explosives Limited (526247) made a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, on BSE related to IPO Listing on February 20, 2026. The sector is noted as technology. No specific details on listing performance, financial metrics, issue price, gains/losses, or other quantitative data are provided in the filing.
20-02-2026
Glenmark Pharmaceuticals Ltd (BSE: 532296) announced a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically regarding ESG Ratings. No quantitative details, financial metrics, changes, or directional impacts on ESG ratings are provided in the filing. This is a regulatory compliance disclosure for an already listed company and unrelated to any IPO activity.
- ·Company BSE code: 532296
- ·Event date: February 20, 2026
- ·Source: BSE
- ·No IPO-related details disclosed; company is already listed
20-02-2026
Globe Civil Projects Ltd (BSE: 544424) announced the outcome of an Analyst/Investor Meet under Regulation 30 of SEBI (LODR) Regulations, 2015, by sharing the link to the audio recording. No financial metrics, performance data, or operational updates are disclosed in this filing. The company operates in the technology sector.
20-02-2026
Aether Industries Ltd (BSE: 543534) has intimated about its ESG rating in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The details of the ESG rating are annexed to the filing, but no specific rating score, changes, or implications are disclosed in the provided summary. No financial metrics, performance comparisons, or other quantitative data are mentioned.
20-02-2026
GRE Renew Enertech Ltd (BSE: 544682) has issued an intimation under Regulation 30 of SEBI LODR regarding the schedule of an Analyst / Institutional Investor(s) Meeting following its IPO listing on February 20, 2026. No specific details such as meeting date, time, venue, participants, or agenda are disclosed in the announcement. This is a routine post-listing compliance disclosure with no financial metrics, performance data, or operational updates provided.
20-02-2026
Patanjali Foods Ltd (500368) disclosed information under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding ESG Rating via BSE on February 20, 2026, labeled as an IPO Listing event. No specific ESG rating score, financial metrics, listing gains/losses, or quantitative details were provided in the filing. This appears to be a compliance disclosure for a listed company with no directional performance indicators.
20-02-2026
Jubilant FoodWorks Ltd (BSE: 533155) has issued an update on the sale of its stake in associate company Hashtag Loyalty Private Ltd under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The disclosure is dated February 20, 2026, from BSE, with the company positioned in the technology sector. No quantitative details such as transaction value, stake percentage, financial impact, or period-over-period metrics are disclosed.
20-02-2026
Exato Technologies Ltd (BSE: 544626), a technology sector company, made a post-IPO listing disclosure on February 20, 2026, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the outcome of an investor meeting. No specific details on the investor meeting outcome, financial metrics, listing performance, business updates, or quantitative data are provided in the filing. This is a routine compliance disclosure with no material information disclosed.
- ·BSE Script Code: 544626
- ·Event Type: IPO Listing
- ·Source: BSE
20-02-2026
Brigade Enterprises Limited (532929) announced under SEBI LODR Regulation 30 a press/media release for the debut of Brigade Group's flagship 'Brigade Showcase' event in Hyderabad on February 21 and 22, 2026, coinciding with the IPO listing date of February 20, 2026 on BSE. No financial metrics, IPO pricing, listing performance, or quantitative data are disclosed. The announcement is purely promotional with no positive or negative performance indicators provided.
20-02-2026
IRB Infrastructure Developers Ltd (BSE: 532947) has intimated under Regulation 30 of SEBI (LODR) Regulations, 2015, about the schedule of analyst and institutional investor meetings. Senior management will hold virtual or in-person meetings/group meetings with investors/analysts at the event 'Chasing Growth 2026' hosted by Kotak Securities. No financial metrics, performance data, IPO details, specific dates, or quantitative information are disclosed in the filing.
20-02-2026
Tata Steel Ltd (BSE: 500470) has issued an intimation under Regulation 30 of SEBI (LODR) Regulations, 2015, regarding the schedule of Analyst / Institutional Investor Meetings. No specific details such as dates, times, participants, or financial metrics are disclosed in the announcement.
20-02-2026
Royal Orchid Hotels Ltd (BSE: 532699) issued an intimation under Regulation 30 of SEBI (LODR) Regulations, 2015, continuing from earlier disclosures dated March 4, 2022 and March 2, 2024, regarding Mr. Pavanjeet Singh. The event is labeled as IPO Listing on BSE dated February 20, 2026, in the technology sector. No financial metrics, IPO details, listing performance, or quantitative data are disclosed in the filing.
20-02-2026
KEC International Limited (BSE: 532714) has disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, an intimation regarding ESG rating assigned by NSE Sustainability Ratings & Analytics Limited, with details enclosed. No specific ESG rating score, financial metrics, performance changes, or quantitative data are mentioned in the filing. This is framed as an IPO listing event dated February 20, 2026, on BSE in the technology sector, but no IPO-related details such as pricing, stages, or listing performance are provided.
20-02-2026
Firstsource Solutions Ltd (BSE: 532809) announced under Regulation 30 of SEBI (LODR) Regulations, 2015, an intimation regarding the schedule of Analyst/Institutional Investor Meetings, with the schedule enclosed. The announcement was sourced from BSE on February 20, 2026, and pertains to a listed technology sector company. No financial metrics, IPO details, performance data, positive or negative changes, or specific meeting schedules/dates are explicitly disclosed in the filing.
20-02-2026
Capri Global Capital Limited intimated BSE under Regulation 30 of SEBI (LODR) Regulations, 2015, regarding its ESG Ratings following IPO listing on February 20, 2026. No specific details on the ESG ratings, financial metrics, or performance indicators are disclosed in the filing. This is an informational disclosure with no quantitative data provided.
20-02-2026
Gravita India Ltd (533282) made an announcement under Regulation 30 of SEBI (LODR) Regulations, 2015, providing an update on its ESG Rating. The disclosure is labeled as an IPO Listing event on BSE dated February 20, 2026, in the technology sector. No specific details on the ESG rating score, changes, financial metrics, or listing performance were disclosed.
- ·Event labeled as IPO Listing on BSE dated February 20, 2026
- ·Sector indicated as technology
20-02-2026
Balgopal Commercial Ltd (BSE: 539834), a technology sector company, has filed an intimation under Regulation 30 (read with Part A of Schedule III) of SEBI (LODR) Regulations, 2015, stating that the Board has acted based on the recommendations of the Audit Committee. No specific details of the board decision, financial metrics, IPO details, or quantitative data are disclosed in the filing excerpt. This appears related to an IPO listing event on February 20, 2026, but lacks confirmation or further context.
20-02-2026
Jungle Camps India Ltd (BSE: 544304) disclosed under Regulation 30 of SEBI LODR a favourable order from the Hon'ble High Court of Madhya Pradesh directing the accused to return ₹1.34 Crore to the company within seven days. This pertains to recovery of funds and represents a positive legal development post-IPO listing on February 20, 2026. No other financial metrics, operational data, or negative aspects are mentioned in the filing.
20-02-2026
CWD Ltd (BSE: 543378), a technology sector company, announced under Regulation 30 of SEBI (LODR) Regulations 2015 an intimation for a Plant Visit for Investors and Analysts following its IPO listing on February 20, 2026. No financial metrics, performance data, or quantitative details are disclosed in the filing. This is a standard post-listing compliance disclosure.
- ·Source: BSE
- ·Event Type: IPO Listing (contextual), Announcement: Plant Visit intimation
20-02-2026
Jindal Steel Ltd (532286) has made an announcement under Regulation 30 of SEBI (LODR) intimating the schedule of Analyst / Institutional Investor Meetings. No specific details on the meeting schedule, dates, or participants are provided in the filing. This is a routine compliance disclosure for a listed company.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 51 filings
🇮🇳 More from India
View all →March 26, 2026
India Pre-Market Regulatory Roundup — March 26, 2026
India Pre-Market Regulatory Roundup
March 26, 2026
India Quarterly Results BSE NSE Announcements — March 26, 2026
India Quarterly Results BSE NSE Announcements
March 26, 2026
India Upcoming Corporate Actions BSE NSE — March 26, 2026
India Upcoming Corporate Actions BSE NSE
March 25, 2026
India Pre-Market Regulatory Roundup — March 25, 2026
India Pre-Market Regulatory Roundup